On Friday, Abeona Therapeutics Inc (NASDAQ: ABEO) was 10.05% up from the session before settling in for the closing price of $4.18. A 52-week range for ABEO has been $3.05 – $8.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -15.07%. When this article was written, the company’s average yearly earnings per share was at 20.86%. With a float of $43.12 million, this company’s outstanding shares have now reached $45.64 million.
Considering the fact that the conglomerate employs 136 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Abeona Therapeutics Inc (ABEO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Abeona Therapeutics Inc stocks. The insider ownership of Abeona Therapeutics Inc is 11.64%, while institutional ownership is 64.23%. The most recent insider transaction that took place on Mar 31 ’25, was worth 119,500. In this transaction Chief Executive Officer of this company sold 25,000 shares at a rate of $4.78, taking the stock ownership to the 1,355,322 shares. Before that another transaction happened on Mar 31 ’25, when Company’s Officer proposed sale 25,000 for $4.78, making the entire transaction worth $119,560.
Abeona Therapeutics Inc (ABEO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 20.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 53.58% during the next five years compared to 47.21% growth over the previous five years of trading.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
You can see what Abeona Therapeutics Inc (ABEO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -0.19 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Compared to the last year’s volume of 0.43 million, its volume of 0.99 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 41.05%. Additionally, its Average True Range was 0.37.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 25.62%, which indicates a significant decrease from 53.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.42% in the past 14 days, which was higher than the 49.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.25, while its 200-day Moving Average is $5.54. Nevertheless, the first resistance level for the watch stands at $4.80 in the near term. At $5.00, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.34. If the price goes on to break the first support level at $4.27, it is likely to go to the next support level at $3.93. Now, if the price goes above the second support level, the third support stands at $3.73.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
There are 48,534K outstanding shares of the company, which has a market capitalization of 223.24 million. As of now, sales total 0 K while income totals -63,730 K. Its latest quarter income was 0 K while its last quarter net income were -9,290 K.
